Elamipretide
- Generic Name
- Elamipretide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C32H49N9O5
- CAS Number
- 736992-21-5
- Unique Ingredient Identifier
- 87GWG91S09
- Background
Elamipretide has been used in trials studying the treatment of Leber's Hereditary Optic Neuropathy.
- Associated Conditions
- -
- Associated Therapies
- -
A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-09-19
- Last Posted Date
- 2020-06-23
- Lead Sponsor
- Stealth BioTherapeutics Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT02245620
- Locations
- 🇺🇸
The University of Washington Medical Center, Seattle, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath